These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 230854)

  • 1. Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.
    Weiland F; Weiland E; Mussgay M
    Br J Cancer; 1979 Dec; 40(6):932-42. PubMed ID: 230854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.
    Weiland E; Mussgay M
    Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants.
    Weiland E; Thiel HJ
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1863-72. PubMed ID: 2993478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells.
    Hunsmann G; Weiland E; Mussgay M; Schneider J
    J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
    Becker S; Haskill S
    Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen.
    Weiland E; Weiland F
    Clin Exp Immunol; 1985 Oct; 62(1):167-75. PubMed ID: 2998658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polykaryocytosis induced by amphotropic murine C-type virus (AP129) in Sac-cells nonproductively transformed by Moloney murine sarcoma virus (MO-MSV).
    Weiland E; Weiland F
    Acta Virol; 1985 Jan; 29(1):79-82. PubMed ID: 2859766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.
    Weiland E; Mussgay M; Weiland F
    J Exp Med; 1978 Aug; 148(2):408-23. PubMed ID: 151722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth.
    Guiliani F; Casazza AM; Soranzo C; Di Marco A
    Br J Cancer; 1977 Feb; 35(2):190-8. PubMed ID: 189792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P; Vallerani E; Biasi G; Landolfo S; Collavo D
    J Immunol; 1988 Feb; 140(4):1341-4. PubMed ID: 2830339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.
    Stephenson JR; Aaronson SA
    J Exp Med; 1972 Mar; 135(3):503-15. PubMed ID: 4550769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
    Cerundolo V; Zanovello P; McIntosh D; Fabbris R; Davies AJ; Collavo D
    Br J Cancer; 1987 Apr; 55(4):413-9. PubMed ID: 2437947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic bone induction at sites of Moloney murine sarcoma virus inoculation in mice.
    Wlodarski K; Kobus M; Luczak M
    Nature; 1979 Oct; 281(5730):386-7. PubMed ID: 225678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.